Login to Your Account

Opdivo, Tafinlar, epacadostat positive for advanced melanoma

By Karen Pihl-Carey
Staff Writer

Monday, September 11, 2017

MADRID, Spain – Enthusiasm among oncologists Monday following positive results from two phase III late-stage melanoma trials – one for an immunotherapy, the other for a combination targeted therapy – suggested Opdivo and Tafinlar may soon replace interferon in Europe and Yervoy in the U.S. at the adjuvant setting.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription